Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Buy
731
+17
+2% +$5.82K 0.08% 549
2026
Q1
$251K Sell
714
-444
-38% -$158K 0.07% 596
2025
Q4
$379K Buy
+1,158
New +$367K 0.13% 308

Other funds holding AMGN

AlphaGrep UK's AMGN Position: Q2 2026 in Review

AlphaGrep UK increased its Amgen (AMGN) stake by 2.4% in Q2 2026, buying an estimated $5.82K and bringing the position to 731 shares worth $265K. The position accounts for 0.08% of the portfolio, ranked #549.

AlphaGrep UK first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $379K in Q4 2025. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • AlphaGrep UK held 731 shares of Amgen worth $265K as of Q2 2026.
  • AlphaGrep UK bought 17 Amgen shares in Q2 2026, an estimated $5.82K.
  • Amgen made up 0.08% of AlphaGrep UK's portfolio in Q2 2026, its #549 holding.
  • AlphaGrep UK first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Amgen position peaked at $379K in Q4 2025.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.